Insider activity at Mural Oncology plc has been all selling for a year now: about $25,000 from two sellers, and zero buyers on the open market.
That's worth context: executives sell for plenty of routine reasons, from scheduled trading plans to tax bills. Buying is the rarer, more telling signal.
Looking at the quarterly pattern: No open-market insider buying or selling in the last full quarter. Insiders bought in 0 of the last 7 full quarters.
| Filed | Insider | Role | Type | Shares | Price | Value | Source |
|---|---|---|---|---|---|---|---|
| Nov 10, 2025 | Cutler Adam D. | CFO | Sell | 7,148 | $2.09 | $15K | SEC |
| Nov 10, 2025 | Goodman Vicki L | Executive Officer | Sell | 5,036 | $2.08 | $10K | SEC |
| Jul 23, 2025 | Keson-Brookes Maiken | Officer | Sell | 2,572 | $2.48 | $6K | SEC |
| Jul 22, 2025 | Keson-Brookes Maiken | Officer | Sell | 2,158 | $2.48 | $5K | SEC |
| Jul 9, 2025 | Loew Caroline | CEO | Sell | 12,531 | $2.43 | $30K | SEC |
| Mar 5, 2025 | Keson-Brookes Maiken | Officer | Sell | 1,262 | $3.36 | $4K | SEC |
| Mar 5, 2025 | Keson-Brookes Maiken | Officer | Sell | 1,469 | $3.45 | $5K | SEC |
| Mar 5, 2025 | Loew Caroline | CEO | Sell | 4,313 | $3.36 | $14K | SEC |
| Feb 25, 2025 | Goodman Vicki L | Executive Officer | Sell | 13,186 | $3.89 | $51K | SEC |
| Dec 26, 2024 | Keson-Brookes Maiken | Officer | Sell | 2,555 | $3.27 | $8K | SEC |
| Dec 18, 2024 | Loew Caroline | CEO | Sell | 2,763 | $3.40 | $9K | SEC |
| Nov 8, 2024 | Goodman Vicki L | Executive Officer | Sell | 5,069 | $3.33 | $17K | SEC |
| Nov 1, 2024 | Cutler Adam D. | CFO | Sell | 7,421 | $3.41 | $25K | SEC |
| Aug 15, 2024 | ALTSCHULLER Susan | Director | Buy | 10,000 | $3.21 | $32K | SEC |
| Jul 18, 2024 | Keson-Brookes Maiken | Officer | Sell | 2,157 | $3.41 | $7K | SEC |
In the last 12 months Mural Oncology plc insiders made open-market purchases worth about $0 and sales worth about $25,000. Data comes from SEC Form 4 filings, updated every 30 minutes on CapitalSnitch.
The most recent open-market insider trade in MURA was filed on 2025-11-10.
No congressional trades in MURA were reported in the past two years. The full list is free on CapitalSnitch.
Public-record data for research and education, not investment advice. Insider sales are often pre-planned (10b5-1). Congress data: Data derived from public disclosures filed under the Ethics in Government Act and the STOCK Act, republished free for public transparency and news reporting. Disclosures may lag the trade by 45 days or more and show amounts only as ranges. This data may not be used for credit rating, loan underwriting, solicitation of money (political, charitable or other), direct-mail or commercial targeting (5 U.S.C. 13107).